A comprehensive view of non-vaccine biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck enters research collaboration with BigHat Biosciences to use BigHat’s AI-enabled design platform Milliner to design candidates for up to three drug discovery programs; Milliner engineers antibodies with complex functions and biophysical properties

Sonic Healthcare invests US$17.8M for 19.9% equity holding in precision microbiome company Microba; deal will offer Microba's microbiome testing technology in US, Australia, Germany, UK, Switzerland, New Zealand and Belgium

FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M

FujiFilm invests US$188.0M in 250,000 square-foot cell culture media manufacturing plant in North Carolina’s Research Triangle Park; facility to expand FujiFilm's capacity to 800,000 kilograms of dry powder and 3,300,000 liters of liquid annually

Novartis to lay off 275 employees when it closes its Libertyville, Illinois, gene therapies manufacturing facility at end of 2023; company to consolidate manufacturing of gene therapy medication Zolgensma at Durham, North Carolina, plant

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count